May 12, 2021
Development of the Hydroxyquinoline Analogue YUM70 as a Novel Inducer of ER Stress in Pancreatic Cancer
Pancreatic cancer remains one of the deadliest human diseases, and there are two first-line regimens for patients with pancreatic cancer. These regimens of gemcitabine/nab-paclitaxel and FOLFIRINOX have shown a survival…
Recent Comments